AAPP Pharmacist Toolkit: Addressing Stimulant Shortages

Sign in (or create a FREE account) to register or access your existing registration.

Course Description

About AAPP Toolkits 

AAPP toolkits highlight both the evidence base available as well as strategies of clinical decision making used by expert psychiatric pharmacist clinicians. The content reflects the views and practice of the authors as substantiated with evidence-based facts as well as opinion and experience. Toolkits are peer reviewed by psychiatric pharmacists. Authors and AAPP review and update toolkits annually and strive to use up-to-date, non-stigmatizing language. Terminology does evolve rapidly and often regionally such that there may be differences between reader experiences and expectations and those of the author(s). AAPP members receive complimentary, continuous access to toolkits. Non-members can purchase for a fee for a period of 3 months. 

Stimulants (e.g., methylphenidate and amphetamine salts) are effective medications for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. This free toolkit is intended to provide an evidence-based guide for thoughtfully converting from one stimulant product formulation to another. The toolkit provides information in the following areas:

  1. General Dosing Considerations
  2. Stimulant Class Comparisons
  3. Stimulant Dose Conversions
  4. Other Important Considerations
  5. References
This toolkit is intended to highlight both the evidence base available as well as strategies of clinical decision making used by expert clinicians. The content reflects the views and practice of the authors as substantiated with evidence-based facts as well as opinion and experience. The opinions and recommendations in this document reflect those of the authors and do not necessarily reflect those of their employers or AAPP.